5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature

Livio Pagano, Mariangela Greco, Marianna Criscuolo, Luana Fianchi, Emiliano Fabiani, Maria Teresa Voso

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

5 Citazioni (Scopus)

Abstract

Hypomethylating drugs are useful in the management of Myelodysplastic syndromes, but there are only few reports on chronic myelomonocycitic (CMML) leukemia patients. We describe our experience in 3 CMML patients treated with azacitidine. Two patients obtained partial response after 4 treatment cycles with only minor toxicity and are in continuous partial response, with stable peripheral blood counts, at 29 and 30 cycles from treatment start.
Lingua originaleEnglish
pagine (da-a)e2011011-e2011011
RivistaMediterranean Journal of Hematology and Infectious Diseases
Volume3
DOI
Stato di pubblicazionePubblicato - 2011

Keywords

  • 5-azacytidine
  • CMML

Fingerprint Entra nei temi di ricerca di '5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature'. Insieme formano una fingerprint unica.

Cita questo